CellWell record HH-233001
Co-designing primary and secondary outcome measures for an international phase 3 trial of surgical de-escalation in vulvar cancer through a consumer workshop
Lauren Angel; Monika Janda; Andrew Martin; Brianna Armstrong; Merran Williams; Nicola Du Thaler; Emma Wild; Mary Li; Andreas Obermair
2026
In plain language
Cancer survivors co-designing a vulvar cancer trial identified shifting priorities: immediate cancer control with tolerance of short-term effects, medium-term quality of life and recurrence fear, long-term avoidance of chronic lymphedema.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-233001
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.